Shanghai Kaibao Pharmaceutical CO.,Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 1,154.33 million compared to CNY 800.01 million a year ago. Revenue was CNY 1,154.33 million compared to CNY 800.01 million a year ago.

Net income was CNY 196.12 million compared to CNY 118.61 million a year ago. Basic earnings per share from continuing operations was CNY 0.1875 compared to CNY 0.1134 a year ago. Diluted earnings per share from continuing operations was CNY 0.1875 compared to CNY 0.1134 a year ago.